Skip to main content

Table 3 Treatment, response and remission rates

From: Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort

Medication

Number of patients who used (%)

No response (%)

Partial response (%)

Remission (%)

NSAID

44 (100)

27/44 (61.4)

11/44 (25)

6/44 (13.6)

Methotrexatea

24 (54.5)

11/24 (45.8)

6/24 (25)

7/24 (29.1)

Pamidronate

6 (13.6)

3/6 (50)

1/6b (16.7)

0

Adalimumab

15 (34)

5/15c (33.3)

6/15 (40)

4/15 (16.7)

Infliximab

7 (15.9)

2/7 (28.6)

3/7 (42.8)

2/7 (28.6)

Etanercept

4 (9.1)

2/4 (50)

1/4 (25)

1/4 (25)

  1. a. Monotherapy; does not include those who received methotrexate as an adjunct to TNF blocker
  2. b. 2 patients have received < 3 months treatment
  3. c. 1 discontinued early due to adverse reaction